APOBEC3G acts as a therapeutic target in mesenchymal gliomas by sensitizing cells to radiation-induced cell death

Yu Wang, Shaofang Wu, Siyuan Zheng, Shuzhen Wang, Arjun Wali, Ravesanker Ezhilarasan, Erik P. Sulman, Dimpy Koul, W. K. Alfred Yung

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Genomic, transcriptional, and proteomic analyses of brain tumors reveal that subtypes differ in their pathway activity, progression, and response to therapy. We performed an expression profiling of Glioma Initiating Cells (GICs) and comparative analysis between different groups of GICs indicates major variations in gene expression. Hierarchical clustering analysis revealed groups of GICs reflecting their heterogeneity, and among some of the genes as major regulators of mesenchymal phenotype, we identified ABOBEC3G as one of the most discriminating genes in mesenchymal group. ABOBEC3G revealed a strong correlation with overall survival in TCGA GBM patient cohorts. APOBEC3G regulates cell invasion and silencing of this gene in GICs inhibits cell invasion and also glioma sphere initiation. APOBEC3G controls invasion through TGFβ/Smad2 pathway by regulating Smad2 target genes Thrombospondin 1, matrix metallopeptidase 2 and TIMP metallopeptidase inhibitor 1. We also show that targeting APOBEC3G can sensitize cancer cells to radiation induced cell death by attenuating activation of the DNA repair pathway. This response is mainly shown by decreased pChk2 expression in knockdown APOBEC3G cells. Taken together, we show that APOBEC3G gene is a mesenchymal enriched gene that controls invasion and knockdown of APOBEC3G sensitizes cells to radiation induced cell death, suggesting that APOBEC3G can be considered for use in stratifying patients with GBM for prognostic considerations.

Original languageEnglish (US)
Pages (from-to)54285-54296
Number of pages12
JournalOncotarget
Volume8
Issue number33
DOIs
StatePublished - Jan 1 2017
Externally publishedYes

Fingerprint

Glioma
Cell Death
Radiation
Therapeutics
Genes
Thrombospondin 1
Tissue Inhibitor of Metalloproteinase-2
Metalloproteases
Gene Silencing
Brain Neoplasms
DNA Repair
Proteomics
Cluster Analysis
Phenotype
Gene Expression
Survival

Keywords

  • APOBEC3G
  • Mesenchymal gliomas
  • Radiation and cell death
  • TGFβ signaling

ASJC Scopus subject areas

  • Oncology

Cite this

APOBEC3G acts as a therapeutic target in mesenchymal gliomas by sensitizing cells to radiation-induced cell death. / Wang, Yu; Wu, Shaofang; Zheng, Siyuan; Wang, Shuzhen; Wali, Arjun; Ezhilarasan, Ravesanker; Sulman, Erik P.; Koul, Dimpy; Alfred Yung, W. K.

In: Oncotarget, Vol. 8, No. 33, 01.01.2017, p. 54285-54296.

Research output: Contribution to journalArticle

Wang, Y, Wu, S, Zheng, S, Wang, S, Wali, A, Ezhilarasan, R, Sulman, EP, Koul, D & Alfred Yung, WK 2017, 'APOBEC3G acts as a therapeutic target in mesenchymal gliomas by sensitizing cells to radiation-induced cell death', Oncotarget, vol. 8, no. 33, pp. 54285-54296. https://doi.org/10.18632/oncotarget.17348
Wang, Yu ; Wu, Shaofang ; Zheng, Siyuan ; Wang, Shuzhen ; Wali, Arjun ; Ezhilarasan, Ravesanker ; Sulman, Erik P. ; Koul, Dimpy ; Alfred Yung, W. K. / APOBEC3G acts as a therapeutic target in mesenchymal gliomas by sensitizing cells to radiation-induced cell death. In: Oncotarget. 2017 ; Vol. 8, No. 33. pp. 54285-54296.
@article{76ed556f8cf349c48e7dd8d3ae79989e,
title = "APOBEC3G acts as a therapeutic target in mesenchymal gliomas by sensitizing cells to radiation-induced cell death",
abstract = "Genomic, transcriptional, and proteomic analyses of brain tumors reveal that subtypes differ in their pathway activity, progression, and response to therapy. We performed an expression profiling of Glioma Initiating Cells (GICs) and comparative analysis between different groups of GICs indicates major variations in gene expression. Hierarchical clustering analysis revealed groups of GICs reflecting their heterogeneity, and among some of the genes as major regulators of mesenchymal phenotype, we identified ABOBEC3G as one of the most discriminating genes in mesenchymal group. ABOBEC3G revealed a strong correlation with overall survival in TCGA GBM patient cohorts. APOBEC3G regulates cell invasion and silencing of this gene in GICs inhibits cell invasion and also glioma sphere initiation. APOBEC3G controls invasion through TGFβ/Smad2 pathway by regulating Smad2 target genes Thrombospondin 1, matrix metallopeptidase 2 and TIMP metallopeptidase inhibitor 1. We also show that targeting APOBEC3G can sensitize cancer cells to radiation induced cell death by attenuating activation of the DNA repair pathway. This response is mainly shown by decreased pChk2 expression in knockdown APOBEC3G cells. Taken together, we show that APOBEC3G gene is a mesenchymal enriched gene that controls invasion and knockdown of APOBEC3G sensitizes cells to radiation induced cell death, suggesting that APOBEC3G can be considered for use in stratifying patients with GBM for prognostic considerations.",
keywords = "APOBEC3G, Mesenchymal gliomas, Radiation and cell death, TGFβ signaling",
author = "Yu Wang and Shaofang Wu and Siyuan Zheng and Shuzhen Wang and Arjun Wali and Ravesanker Ezhilarasan and Sulman, {Erik P.} and Dimpy Koul and {Alfred Yung}, {W. K.}",
year = "2017",
month = "1",
day = "1",
doi = "10.18632/oncotarget.17348",
language = "English (US)",
volume = "8",
pages = "54285--54296",
journal = "Oncotarget",
issn = "1949-2553",
publisher = "Impact Journals",
number = "33",

}

TY - JOUR

T1 - APOBEC3G acts as a therapeutic target in mesenchymal gliomas by sensitizing cells to radiation-induced cell death

AU - Wang, Yu

AU - Wu, Shaofang

AU - Zheng, Siyuan

AU - Wang, Shuzhen

AU - Wali, Arjun

AU - Ezhilarasan, Ravesanker

AU - Sulman, Erik P.

AU - Koul, Dimpy

AU - Alfred Yung, W. K.

PY - 2017/1/1

Y1 - 2017/1/1

N2 - Genomic, transcriptional, and proteomic analyses of brain tumors reveal that subtypes differ in their pathway activity, progression, and response to therapy. We performed an expression profiling of Glioma Initiating Cells (GICs) and comparative analysis between different groups of GICs indicates major variations in gene expression. Hierarchical clustering analysis revealed groups of GICs reflecting their heterogeneity, and among some of the genes as major regulators of mesenchymal phenotype, we identified ABOBEC3G as one of the most discriminating genes in mesenchymal group. ABOBEC3G revealed a strong correlation with overall survival in TCGA GBM patient cohorts. APOBEC3G regulates cell invasion and silencing of this gene in GICs inhibits cell invasion and also glioma sphere initiation. APOBEC3G controls invasion through TGFβ/Smad2 pathway by regulating Smad2 target genes Thrombospondin 1, matrix metallopeptidase 2 and TIMP metallopeptidase inhibitor 1. We also show that targeting APOBEC3G can sensitize cancer cells to radiation induced cell death by attenuating activation of the DNA repair pathway. This response is mainly shown by decreased pChk2 expression in knockdown APOBEC3G cells. Taken together, we show that APOBEC3G gene is a mesenchymal enriched gene that controls invasion and knockdown of APOBEC3G sensitizes cells to radiation induced cell death, suggesting that APOBEC3G can be considered for use in stratifying patients with GBM for prognostic considerations.

AB - Genomic, transcriptional, and proteomic analyses of brain tumors reveal that subtypes differ in their pathway activity, progression, and response to therapy. We performed an expression profiling of Glioma Initiating Cells (GICs) and comparative analysis between different groups of GICs indicates major variations in gene expression. Hierarchical clustering analysis revealed groups of GICs reflecting their heterogeneity, and among some of the genes as major regulators of mesenchymal phenotype, we identified ABOBEC3G as one of the most discriminating genes in mesenchymal group. ABOBEC3G revealed a strong correlation with overall survival in TCGA GBM patient cohorts. APOBEC3G regulates cell invasion and silencing of this gene in GICs inhibits cell invasion and also glioma sphere initiation. APOBEC3G controls invasion through TGFβ/Smad2 pathway by regulating Smad2 target genes Thrombospondin 1, matrix metallopeptidase 2 and TIMP metallopeptidase inhibitor 1. We also show that targeting APOBEC3G can sensitize cancer cells to radiation induced cell death by attenuating activation of the DNA repair pathway. This response is mainly shown by decreased pChk2 expression in knockdown APOBEC3G cells. Taken together, we show that APOBEC3G gene is a mesenchymal enriched gene that controls invasion and knockdown of APOBEC3G sensitizes cells to radiation induced cell death, suggesting that APOBEC3G can be considered for use in stratifying patients with GBM for prognostic considerations.

KW - APOBEC3G

KW - Mesenchymal gliomas

KW - Radiation and cell death

KW - TGFβ signaling

UR - http://www.scopus.com/inward/record.url?scp=85029041634&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85029041634&partnerID=8YFLogxK

U2 - 10.18632/oncotarget.17348

DO - 10.18632/oncotarget.17348

M3 - Article

AN - SCOPUS:85029041634

VL - 8

SP - 54285

EP - 54296

JO - Oncotarget

JF - Oncotarget

SN - 1949-2553

IS - 33

ER -